 Daniel Olson
Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dengue | 3 | 2022 | 60 | 1.510 |
Why?
| | Guatemala | 16 | 2023 | 296 | 1.500 |
Why?
| | Arbovirus Infections | 2 | 2019 | 18 | 1.340 |
Why?
| | Caliciviridae Infections | 2 | 2018 | 17 | 1.250 |
Why?
| | Zika Virus Infection | 4 | 2022 | 85 | 1.250 |
Why?
| | Norovirus | 2 | 2018 | 23 | 1.240 |
Why?
| | Microcephaly | 3 | 2023 | 54 | 1.230 |
Why?
| | Viral Vaccines | 2 | 2018 | 90 | 1.210 |
Why?
| | Dengue Virus | 3 | 2022 | 31 | 1.200 |
Why?
| | Gastroenteritis | 2 | 2017 | 64 | 1.160 |
Why?
| | Zika Virus | 3 | 2022 | 61 | 1.020 |
Why?
| | Vital Signs | 2 | 2013 | 42 | 0.910 |
Why?
| | Disease Outbreaks | 3 | 2019 | 322 | 0.810 |
Why?
| | Triage | 2 | 2013 | 203 | 0.770 |
Why?
| | Hospitals | 4 | 2016 | 598 | 0.770 |
Why?
| | Stevens-Johnson Syndrome | 2 | 2017 | 34 | 0.750 |
Why?
| | Sentinel Surveillance | 2 | 2017 | 39 | 0.750 |
Why?
| | Global Health | 2 | 2022 | 310 | 0.740 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2018 | 1185 | 0.720 |
Why?
| | Fever | 2 | 2017 | 283 | 0.680 |
Why?
| | Public Health | 2 | 2019 | 450 | 0.610 |
Why?
| | Rural Population | 7 | 2022 | 452 | 0.610 |
Why?
| | Cell Phone | 1 | 2017 | 81 | 0.580 |
Why?
| | Child Development | 4 | 2022 | 410 | 0.560 |
Why?
| | Health Policy | 1 | 2019 | 333 | 0.540 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 12 | 0.530 |
Why?
| | Mobile Applications | 1 | 2017 | 147 | 0.530 |
Why?
| | Infant | 17 | 2023 | 8293 | 0.530 |
Why?
| | Typhoid Fever | 1 | 2015 | 10 | 0.530 |
Why?
| | Health Information Systems | 1 | 2015 | 18 | 0.520 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2674 | 0.520 |
Why?
| | Meningitis, Bacterial | 1 | 2015 | 51 | 0.510 |
Why?
| | Paralysis | 1 | 2015 | 67 | 0.500 |
Why?
| | Malaria | 1 | 2015 | 60 | 0.490 |
Why?
| | Population Surveillance | 1 | 2017 | 413 | 0.480 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 112 | 0.480 |
Why?
| | Child, Preschool | 16 | 2022 | 9491 | 0.470 |
Why?
| | Communicable Diseases | 1 | 2015 | 132 | 0.450 |
Why?
| | Allied Health Personnel | 1 | 2013 | 44 | 0.450 |
Why?
| | Developing Countries | 2 | 2019 | 255 | 0.440 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 687 | 0.440 |
Why?
| | Hospitalization | 4 | 2015 | 1785 | 0.440 |
Why?
| | Growth Disorders | 2 | 2023 | 77 | 0.430 |
Why?
| | Hospital Mortality | 2 | 2013 | 814 | 0.420 |
Why?
| | Health Resources | 1 | 2013 | 132 | 0.420 |
Why?
| | Child | 13 | 2022 | 19129 | 0.370 |
Why?
| | Databases, Factual | 1 | 2015 | 1231 | 0.360 |
Why?
| | HIV Infections | 4 | 2015 | 2459 | 0.320 |
Why?
| | Mycoplasma pneumoniae | 2 | 2017 | 33 | 0.310 |
Why?
| | Humans | 32 | 2023 | 118974 | 0.300 |
Why?
| | Cross-Sectional Studies | 5 | 2022 | 4552 | 0.300 |
Why?
| | Family Characteristics | 2 | 2018 | 156 | 0.300 |
Why?
| | Serogroup | 2 | 2017 | 34 | 0.300 |
Why?
| | Infant, Newborn | 10 | 2022 | 5255 | 0.290 |
Why?
| | Acute Disease | 2 | 2017 | 940 | 0.250 |
Why?
| | Culex | 1 | 2023 | 16 | 0.240 |
Why?
| | Malawi | 5 | 2014 | 50 | 0.230 |
Why?
| | Aedes | 1 | 2023 | 53 | 0.230 |
Why?
| | Adolescent | 7 | 2018 | 18480 | 0.220 |
Why?
| | Vomiting | 1 | 2023 | 123 | 0.220 |
Why?
| | Cough | 1 | 2023 | 102 | 0.220 |
Why?
| | Male | 17 | 2020 | 57801 | 0.220 |
Why?
| | Cross Reactions | 1 | 2022 | 116 | 0.220 |
Why?
| | Viruses | 1 | 2023 | 96 | 0.220 |
Why?
| | Seroepidemiologic Studies | 1 | 2022 | 146 | 0.210 |
Why?
| | Masks | 1 | 2022 | 48 | 0.210 |
Why?
| | Diarrhea | 1 | 2023 | 181 | 0.210 |
Why?
| | Yellow fever virus | 1 | 2020 | 3 | 0.190 |
Why?
| | Yellow Fever | 1 | 2020 | 7 | 0.190 |
Why?
| | Prospective Studies | 7 | 2023 | 6471 | 0.190 |
Why?
| | Neuropsychological Tests | 3 | 2020 | 1032 | 0.180 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 827 | 0.180 |
Why?
| | Health Services Research | 2 | 2013 | 385 | 0.180 |
Why?
| | Language Tests | 1 | 2019 | 31 | 0.180 |
Why?
| | Language Development Disorders | 1 | 2019 | 40 | 0.170 |
Why?
| | Americas | 1 | 2019 | 23 | 0.170 |
Why?
| | Motor Skills | 1 | 2020 | 85 | 0.170 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2020 | 333 | 0.170 |
Why?
| | Antibodies, Viral | 1 | 2022 | 542 | 0.170 |
Why?
| | Arboviruses | 1 | 2018 | 9 | 0.170 |
Why?
| | Dengue Vaccines | 1 | 2018 | 9 | 0.170 |
Why?
| | Female | 16 | 2020 | 61565 | 0.170 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 4708 | 0.170 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 1795 | 0.160 |
Why?
| | Cities | 2 | 2016 | 96 | 0.160 |
Why?
| | Referral and Consultation | 2 | 2013 | 648 | 0.160 |
Why?
| | Mycoplasma Infections | 1 | 2017 | 12 | 0.160 |
Why?
| | Chlamydophila pneumoniae | 1 | 2017 | 11 | 0.160 |
Why?
| | Chikungunya Fever | 1 | 2018 | 63 | 0.160 |
Why?
| | Mouth Mucosa | 1 | 2017 | 82 | 0.150 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2017 | 33 | 0.150 |
Why?
| | Antigens, Viral | 1 | 2017 | 181 | 0.150 |
Why?
| | RNA, Viral | 1 | 2020 | 572 | 0.140 |
Why?
| | Analgesia, Obstetrical | 1 | 2016 | 16 | 0.140 |
Why?
| | Analgesia, Epidural | 1 | 2016 | 21 | 0.140 |
Why?
| | Neonatal Screening | 1 | 2017 | 152 | 0.140 |
Why?
| | ROC Curve | 2 | 2017 | 473 | 0.140 |
Why?
| | Learning | 1 | 2020 | 374 | 0.140 |
Why?
| | Point-of-Care Systems | 2 | 2014 | 151 | 0.130 |
Why?
| | Pneumococcal Infections | 1 | 2016 | 96 | 0.130 |
Why?
| | Reference Values | 2 | 2014 | 774 | 0.130 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 505 | 0.130 |
Why?
| | Caregivers | 1 | 2021 | 709 | 0.130 |
Why?
| | Data Collection | 1 | 2018 | 658 | 0.130 |
Why?
| | Streptococcus pneumoniae | 1 | 2016 | 141 | 0.130 |
Why?
| | Clinical Medicine | 1 | 2014 | 20 | 0.120 |
Why?
| | Travel | 1 | 2015 | 116 | 0.120 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 267 | 0.120 |
Why?
| | Clinical Laboratory Techniques | 1 | 2014 | 89 | 0.120 |
Why?
| | Cohort Studies | 3 | 2020 | 5116 | 0.120 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2014 | 95 | 0.110 |
Why?
| | Risk Factors | 2 | 2017 | 9000 | 0.110 |
Why?
| | Child, Hospitalized | 1 | 2013 | 43 | 0.110 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2014 | 156 | 0.110 |
Why?
| | Area Under Curve | 1 | 2013 | 296 | 0.110 |
Why?
| | Respiration | 1 | 2013 | 183 | 0.110 |
Why?
| | Confidence Intervals | 1 | 2013 | 324 | 0.110 |
Why?
| | Psychometrics | 3 | 2021 | 631 | 0.110 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2016 | 296 | 0.110 |
Why?
| | Workload | 1 | 2013 | 128 | 0.110 |
Why?
| | Anti-Retroviral Agents | 1 | 2014 | 208 | 0.100 |
Why?
| | Reproducibility of Results | 4 | 2021 | 2874 | 0.100 |
Why?
| | Aged, 80 and over | 1 | 2023 | 6561 | 0.100 |
Why?
| | Survival Analysis | 1 | 2015 | 1267 | 0.100 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2013 | 233 | 0.100 |
Why?
| | Health Personnel | 2 | 2014 | 588 | 0.100 |
Why?
| | Temperature | 1 | 2013 | 622 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 218 | 0.090 |
Why?
| | Odds Ratio | 1 | 2013 | 996 | 0.090 |
Why?
| | Sepsis | 1 | 2016 | 531 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2017 | 1510 | 0.090 |
Why?
| | Heart Rate | 1 | 2013 | 729 | 0.090 |
Why?
| | Oxygen | 1 | 2013 | 854 | 0.080 |
Why?
| | Pneumonia | 1 | 2013 | 592 | 0.080 |
Why?
| | Logistic Models | 1 | 2013 | 1901 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 984 | 0.080 |
Why?
| | Communication | 1 | 2013 | 761 | 0.070 |
Why?
| | Inflammation | 1 | 2017 | 2566 | 0.070 |
Why?
| | Algorithms | 1 | 2014 | 1541 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2013 | 3171 | 0.070 |
Why?
| | Quality Improvement | 1 | 2013 | 963 | 0.070 |
Why?
| | Delivery of Health Care | 1 | 2012 | 867 | 0.070 |
Why?
| | Adult | 4 | 2018 | 31512 | 0.060 |
Why?
| | Mosquito Vectors | 1 | 2023 | 21 | 0.060 |
Why?
| | Animals | 3 | 2023 | 33381 | 0.060 |
Why?
| | Chickens | 1 | 2023 | 185 | 0.060 |
Why?
| | Brain | 1 | 2015 | 2490 | 0.060 |
Why?
| | Personal Protective Equipment | 1 | 2022 | 50 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 89 | 0.050 |
Why?
| | Anthropometry | 1 | 2022 | 194 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 253 | 0.050 |
Why?
| | International Cooperation | 1 | 2022 | 177 | 0.050 |
Why?
| | Paraguay | 1 | 2020 | 3 | 0.050 |
Why?
| | Sri Lanka | 1 | 2020 | 12 | 0.050 |
Why?
| | Endemic Diseases | 1 | 2020 | 28 | 0.050 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2020 | 42 | 0.050 |
Why?
| | Translations | 1 | 2020 | 17 | 0.050 |
Why?
| | Regression Analysis | 1 | 2022 | 983 | 0.040 |
Why?
| | Child Language | 1 | 2019 | 22 | 0.040 |
Why?
| | Translating | 1 | 2019 | 35 | 0.040 |
Why?
| | Rural Health | 1 | 2019 | 72 | 0.040 |
Why?
| | Culturally Competent Care | 1 | 2019 | 53 | 0.040 |
Why?
| | United States | 1 | 2015 | 12555 | 0.040 |
Why?
| | Viral Load | 1 | 2020 | 419 | 0.040 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 85 | 0.040 |
Why?
| | Epitope Mapping | 1 | 2017 | 49 | 0.040 |
Why?
| | Contact Tracing | 1 | 2017 | 16 | 0.040 |
Why?
| | Molecular Epidemiology | 1 | 2017 | 69 | 0.040 |
Why?
| | Macrolides | 1 | 2017 | 57 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2017 | 336 | 0.040 |
Why?
| | Colorado | 2 | 2017 | 4196 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2017 | 302 | 0.030 |
Why?
| | Community-Acquired Infections | 1 | 2017 | 143 | 0.030 |
Why?
| | Pregnancy | 2 | 2017 | 5691 | 0.030 |
Why?
| | Pneumococcal Vaccines | 1 | 2016 | 140 | 0.030 |
Why?
| | World Health Organization | 1 | 2014 | 107 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1355 | 0.030 |
Why?
| | Urban Population | 1 | 2016 | 409 | 0.030 |
Why?
| | Random Allocation | 1 | 2014 | 344 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2017 | 2071 | 0.030 |
Why?
| | HIV | 1 | 2012 | 210 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1284 | 0.020 |
Why?
| | Inpatients | 1 | 2014 | 388 | 0.020 |
Why?
| | DNA, Viral | 1 | 2012 | 356 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1012 | 0.020 |
Why?
| | Middle Aged | 2 | 2017 | 27617 | 0.020 |
Why?
| | Young Adult | 1 | 2017 | 10793 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2016 | 12978 | 0.010 |
Why?
|
|
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|